Mutations in the Na+/Citrate Cotransporter NaCT (SLC13A5) in Pediatric Patients with Epilepsy and Developmental Delay
Abstract Mutations in the SLC13A5 gene that codes for the Na+/citrate cotransporter, NaCT, are associated with early onset epilepsy, developmental delay and tooth dysplasia in children. In this study, we identify additional SLC13A5 mutations in nine epilepsy patients from six families. To better cha...
Saved in:
Main Authors: | Jenna Klotz (Author), Brenda E Porter (Author), Claire Colas (Author), Avner Schlessinger (Author), Ana M Pajor (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice
by: Sebastian Brachs, et al.
Published: (2016) -
The role of SLC12A family of cation-chloride cotransporters and drug discovery methodologies
by: Shiyao Zhang, et al.
Published: (2023) -
Toward a Systematic Structural and Functional Annotation of Solute Carriers Transporters-Example of the SLC6 and SLC7 Families
by: Claire Colas
Published: (2020) -
Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT
by: Tatit Nurseta, et al.
Published: (2022) -
Polymorphisms in the SLC12A3 Gene Encoding Sodium-Chloride Cotransporter are Associated with Hypertension: A Family-Based Study in the Mongolian Population
by: Caiyan An, et al.
Published: (2016)